IGHD1OR15-1B

Across TCGA pan-cancer cohorts, IGHD1OR15-1B RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated IGHD1OR15-1B data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher IGHD1OR15-1B RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated IGHD1OR15-1B expression acts as an unfavorable survival marker.

LUSC and STAD are the cancer types where IGHD1OR15-1B RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	III,IV	0.010	0.754	<.001	72	view →
STAD	OS	Tertile	II,III,IV	0.215	0.660	.019	36	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

IGHD1OR15-1B–LUSC (DFS)

Open the LUSC breakdown →